<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Sasse C</submitter><funding>Deutsche Forschungsgemeinschaft</funding><funding>Interdisciplinary Center for Clinical Research (IZKF), Universitätsklinikum Erlangen</funding><funding>Federal Ministry of Education and Research</funding><pagination>828</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9331382</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(8)</volume><pubmed_abstract>Interleukin (IL)-4 plays a central role in the initiation of a type 2 T helper cell (Th2) response, which leads to non-healing and progressive infections with the protozoan parasite &lt;i>Leishmania&lt;/i> (&lt;i>L.&lt;/i>) &lt;i>major&lt;/i>. Here, we tested the hypothesis that type 2 innate lymphoid cells (ILC2), which promote the development of Th2 cells, form an important source of IL-4 early after intradermal or subcutaneous &lt;i>L. major&lt;/i> infection. Lineage-marker negative CD90.2&lt;sup>+&lt;/sup>CD127&lt;sup>+&lt;/sup>PD1&lt;sup>-&lt;/sup> ILC2 were readily detectable in the ear or foot skin, but hardly in the draining lymph nodes of both naïve and &lt;i>L. major&lt;/i>-infected self-healing C57BL/6 and non-healing BALB/c mice and made up approximately 20% to 30% of all CD45&lt;sup>+&lt;/sup>SiglecF&lt;sup>-&lt;/sup> cells. Dermal ILC</pubmed_abstract><journal>Pathogens (Basel, Switzerland)</journal><pubmed_title>Eosinophils, but Not Type 2 Innate Lymphoid Cells, Are the Predominant Source of Interleukin 4 during the Innate Phase of &lt;i>Leishmania major&lt;/i> Infection.</pubmed_title><pmcid>PMC9331382</pmcid><funding_grant_id>CRC1181 (project C4); RTG2740 (project A6 and B2); SPP1937 (BO996/5-1 and 5-2;SCHL615/1-1 and 1-2)</funding_grant_id><funding_grant_id>Project A87</funding_grant_id><funding_grant_id>031L0126</funding_grant_id><pubmed_authors>Schleicher U</pubmed_authors><pubmed_authors>Bogdan C</pubmed_authors><pubmed_authors>Debus A</pubmed_authors><pubmed_authors>Obermeyer S</pubmed_authors><pubmed_authors>Sasse C</pubmed_authors><pubmed_authors>Barinberg D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Eosinophils, but Not Type 2 Innate Lymphoid Cells, Are the Predominant Source of Interleukin 4 during the Innate Phase of &lt;i>Leishmania major&lt;/i> Infection.</name><description>Interleukin (IL)-4 plays a central role in the initiation of a type 2 T helper cell (Th2) response, which leads to non-healing and progressive infections with the protozoan parasite &lt;i>Leishmania&lt;/i> (&lt;i>L.&lt;/i>) &lt;i>major&lt;/i>. Here, we tested the hypothesis that type 2 innate lymphoid cells (ILC2), which promote the development of Th2 cells, form an important source of IL-4 early after intradermal or subcutaneous &lt;i>L. major&lt;/i> infection. Lineage-marker negative CD90.2&lt;sup>+&lt;/sup>CD127&lt;sup>+&lt;/sup>PD1&lt;sup>-&lt;/sup> ILC2 were readily detectable in the ear or foot skin, but hardly in the draining lymph nodes of both naïve and &lt;i>L. major&lt;/i>-infected self-healing C57BL/6 and non-healing BALB/c mice and made up approximately 20% to 30% of all CD45&lt;sup>+&lt;/sup>SiglecF&lt;sup>-&lt;/sup> cells. Dermal ILC</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jul</publication><modification>2025-05-18T13:32:32.153Z</modification><creation>2025-05-18T13:32:32.153Z</creation></dates><accession>S-EPMC9331382</accession><cross_references><pubmed>35894051</pubmed><doi>10.3390/pathogens11080828</doi></cross_references></HashMap>